Literature DB >> 16432691

Calcium oxalate saturation in dialysis patients with and without primary hyperoxaluria.

Yoshihide Ogawa1, Noriko Machida, Tomohide Ogawa, Masami Oda, Sanehiro Hokama, Yoshiaki Chinen, Atsushi Uchida, Makoto Morozumi, Kimio Sugaya, Yaeko Motoyoshi, Motofumi Hattori.   

Abstract

Calcium oxalate supersaturation of the blood is associated with deposition of crystals in various tissues. We measured the serum levels of oxalate, citrate, calcium, and magnesium to estimate their saturation in 112 hemodialysis patients without primary hyperoxaluria and two boys with primary hyperoxaluria. Serum levels of oxalate and citrate were determined by high-performance capillary electrophoresis, while calcium and magnesium were measured by ICP spectroscopy. The serum levels of oxalate, citrate, calcium, and magnesium were 44.9+/-16.5, 138.1+/-54.9 micromol/l, 2.30+/-0.28, and 1.07+/-0.18 mmol/l, respectively, while the levels in patients with primary hyperoxaluria were 83.9+/-34.3, 197.9+/-63.5 micromol/l, 2.53+/-0.15, and 1.14+/-0.34 mmol/l, respectively. Serum calcium oxalate saturation (SS), as calculated by the Equil program, was significantly correlated with the serum oxalate level. Most patients showed metastable supersaturation (1<SS<8.9), which was associated with a serum oxalate level of more than 30 micromol/l. Serum saturation exceeded the formation product (SS=8.9) in some specimens from patients with type 1 primary hyperoxaluria. The serum calcium oxalate saturation [SS(CaOx)] showed a significant positive correlation with the levels of oxalate [Ox], calcium [Ca], and citrate [Cit]: [SS(CaOx)]=-0.3562+34.634[Ox]+0.394[Ca]-0.483[Mg]+0.101[Cit], (all mmol/l, r=0.9848, P<0.01). This formula is useful for estimating the saturation. In conclusion, the serum oxalate level is a good indicator of calcium oxalate saturation and should be monitored accurately while keeping it lower in dialysis patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16432691     DOI: 10.1007/s00240-005-0004-6

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  35 in total

1.  CRYSTALS OF CALCIUM OXALATE IN KIDNEYS IN UREMIA.

Authors:  H FANGER; A ESPARZA
Journal:  Am J Clin Pathol       Date:  1964-06       Impact factor: 2.493

2.  Factors contributing to oxalate deposits in the myocardia of hemodialysis patients.

Authors:  K Ono; K Kikawa
Journal:  ASAIO Trans       Date:  1989 Jul-Sep

3.  Risk factors in urinary calcium oxalate stone formation and their relation to urinary calcium oxalate supersaturation.

Authors:  Y Ogawa; T Hatano
Journal:  Int J Urol       Date:  1996-09       Impact factor: 3.369

4.  Secondary oxalosis of bone in chronic renal failure. A histopathological study of three cases.

Authors:  J W Milgram; W R Salyer
Journal:  J Bone Joint Surg Am       Date:  1974-03       Impact factor: 5.284

Review 5.  Role of renal epithelial cells in the initiation of calcium oxalate stones.

Authors:  Saeed R Khan
Journal:  Nephron Exp Nephrol       Date:  2004

6.  COM crystals activate the p38 mitogen-activated protein kinase signal transduction pathway in renal epithelial cells.

Authors:  Hari K Koul; Mani Menon; Lakshmi S Chaturvedi; Sweaty Koul; Avtar Sekhon; Akshay Bhandari; Meiyi Huang
Journal:  J Biol Chem       Date:  2002-07-16       Impact factor: 5.157

7.  Vascular and soft tissue calcification in systemic oxalosis: CT diagnosis.

Authors:  M F Glickstein; A M Haggar; B G Coleman
Journal:  J Comput Assist Tomogr       Date:  1986 Jul-Aug       Impact factor: 1.826

8.  Thresholds of serum calcium oxalate supersaturation in relation to renal function in patients with or without primary hyperoxaluria.

Authors:  M Marangella; D Cosseddu; M Petrarulo; C Vitale; F Linari
Journal:  Nephrol Dial Transplant       Date:  1993       Impact factor: 5.992

9.  An improved method for the routine biochemical evaluation of patients with recurrent calcium oxalate stone disease.

Authors:  H G Tiselius
Journal:  Clin Chim Acta       Date:  1982-07-15       Impact factor: 3.786

10.  Evidence that serum calcium oxalate supersaturation is a consequence of oxalate retention in patients with chronic renal failure.

Authors:  E M Worcester; Y Nakagawa; D A Bushinsky; F L Coe
Journal:  J Clin Invest       Date:  1986-06       Impact factor: 14.808

View more
  6 in total

1.  Orthosiphon grandiflorum has a protective effect in a calcium oxalate stone forming rat model.

Authors:  Wongsawat Akanae; Masao Tsujihata; Iwao Yoshioka; Norio Nonomura; Akihiko Okuyama
Journal:  Urol Res       Date:  2010-03-10

Review 2.  Oxalate, inflammasome, and progression of kidney disease.

Authors:  Theresa Ermer; Kai-Uwe Eckardt; Peter S Aronson; Felix Knauf
Journal:  Curr Opin Nephrol Hypertens       Date:  2016-07       Impact factor: 2.894

Review 3.  Dietary Oxalate Intake and Kidney Outcomes.

Authors:  Matteo Bargagli; Maria Clarissa Tio; Sushrut S Waikar; Pietro Manuel Ferraro
Journal:  Nutrients       Date:  2020-09-02       Impact factor: 5.717

Review 4.  Treatment of primary hyperoxaluria type 1.

Authors:  Asheeta Gupta; Michael J G Somers; Michelle A Baum
Journal:  Clin Kidney J       Date:  2022-05-17

5.  High Oxalate Concentrations Correlate with Increased Risk for Sudden Cardiac Death in Dialysis Patients.

Authors:  Anja Pfau; Theresa Ermer; Steven G Coca; Maria Clarissa Tio; Bernd Genser; Martin Reichel; Fredric O Finkelstein; Winfried März; Christoph Wanner; Sushrut S Waikar; Kai-Uwe Eckardt; Peter S Aronson; Christiane Drechsler; Felix Knauf
Journal:  J Am Soc Nephrol       Date:  2021-07-19       Impact factor: 14.978

6.  Impact of Regular or Extended Hemodialysis and Hemodialfiltration on Plasma Oxalate Concentrations in Patients With End-Stage Renal Disease.

Authors:  Theresa Ermer; Christoph Kopp; John R Asplin; Ignacio Granja; Mark A Perazella; Martin Reichel; Thomas D Nolin; Kai-Uwe Eckardt; Peter S Aronson; Fredric O Finkelstein; Felix Knauf
Journal:  Kidney Int Rep       Date:  2017-06-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.